furosemide has been researched along with Cushing Syndrome in 14 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both aldosterone and PRA were to some extent stimulated by an association of dexamethasone and furosemide." | 5.26 | Plasma renin activity and urinary aldosterone in Cushing's syndrome. ( Armanini, D; Boscaro, M; Mantero, F, 1978) |
| " Followed by hydration with saline, pamidronate is effective for the control of symptomatic hypercalcemia." | 4.79 | [Paraneoplastic syndrome]. ( Hara, N; Nakanishi, Y; Takayama, K, 1997) |
| "After the operation, her congestive heart failure and hyperglycemia dramatically improved." | 1.30 | Surgical successful treatment of Cushing's syndrome in a pregnant patient complicated with severe cardiac involvement. ( Hibino, T; Iwata, H; Jin-no, Y; Kajiura, S; Kamiya, Y; Kobayashi, S; Okada, M; Suzuki, Y; Watanabe, O; Yoneyama, A, 1998) |
| "Both aldosterone and PRA were to some extent stimulated by an association of dexamethasone and furosemide." | 1.26 | Plasma renin activity and urinary aldosterone in Cushing's syndrome. ( Armanini, D; Boscaro, M; Mantero, F, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sekihara, H | 1 |
| Ohsawa, N | 1 |
| Baba, T | 1 |
| Aoyagi, K | 1 |
| Murabayashi, S | 1 |
| Sasaki, K | 1 |
| Nigawara, K | 1 |
| Takebe, K | 1 |
| Ganguly, A | 2 |
| Weinberger, MH | 1 |
| Grim, CE | 1 |
| Park, YK | 1 |
| Kim, YW | 1 |
| Kim, JW | 1 |
| Choi, YK | 1 |
| Ko, YT | 1 |
| Ko, SW | 1 |
| Yang, MH | 1 |
| Nakanishi, Y | 1 |
| Takayama, K | 1 |
| Hara, N | 1 |
| Daidoh, H | 1 |
| Morita, H | 1 |
| Hanafusa, J | 1 |
| Mune, T | 1 |
| Murase, H | 1 |
| Sato, M | 1 |
| Shibata, T | 1 |
| Suwa, T | 1 |
| Ishizuka, T | 1 |
| Yasuda, K | 1 |
| Kamiya, Y | 1 |
| Okada, M | 1 |
| Yoneyama, A | 1 |
| Jin-no, Y | 1 |
| Hibino, T | 1 |
| Watanabe, O | 1 |
| Kajiura, S | 1 |
| Suzuki, Y | 1 |
| Iwata, H | 1 |
| Kobayashi, S | 1 |
| Meikle, AW | 1 |
| Tyler, FH | 1 |
| West, CD | 1 |
| Mantero, F | 1 |
| Armanini, D | 1 |
| Boscaro, M | 1 |
| Cugini, P | 1 |
| Scavo, D | 1 |
| Toyozaki, N | 1 |
| Suzuki, T | 1 |
| Ito, T | 2 |
| Fukuchi, S | 2 |
| Takenouchi, T | 2 |
| Nakajima, K | 2 |
| Hidaka, H | 1 |
| Kato, T | 1 |
| Yoshitoski, Y | 1 |
| Nishisato, K | 1 |
1 review available for furosemide and Cushing Syndrome
| Article | Year |
|---|---|
[Paraneoplastic syndrome].
Topics: Alendronate; Anticoagulants; Cushing Syndrome; Diagnosis, Differential; Diphosphonates; Disseminated | 1997 |
13 other studies available for furosemide and Cushing Syndrome
| Article | Year |
|---|---|
19-hydroxyandrostenedione, a new amplifier of the action of aldosterone, in low renin essential hypertension.
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Cushing Syndrome; Female | 1982 |
Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Captopril; Cushing Syndrome; F | 1983 |
The renin-angiotensin-aldosterone system in Cushing's syndrome and pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Catecholamines; Cushing Syndrome; Female; Furosemide; Hu | 1983 |
Bilateral primary pigmented nodular adrenocortical disease--a case of report describing a rare cause of Cushing's syndrome.
Topics: Adipose Tissue; Adrenal Cortex; Adrenalectomy; Adult; Atrophy; Cushing Syndrome; Dexamethasone; Furo | 1994 |
In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Antidiuretic Hormone Receptor Antagonists; Arginine Vas | 1998 |
Surgical successful treatment of Cushing's syndrome in a pregnant patient complicated with severe cardiac involvement.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Cardiotonic Agents; | 1998 |
Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; | 1977 |
Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Child; | 1978 |
[Reliability and diagnostic use of the furosemide test in the study of the renin-angiotensin-aldosterone system].
Topics: Adolescent; Adult; Aldosterone; Cushing Syndrome; Electrolytes; Female; Furosemide; Humans; Hyperten | 1978 |
[Plasma renin substrate in normal subjects and various diseases--influence of sodium chloride and various medicines].
Topics: Adult; Aged; Angiotensinogen; Captopril; Cushing Syndrome; Female; Furosemide; Humans; Hyperaldoster | 1987 |
Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.
Topics: Angiotensin II; Cushing Syndrome; Enzyme Activation; Furosemide; Glomerulonephritis; Humans; Hyperal | 1973 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
Plasma aldosterone in essential hypertension with low renin activity.
Topics: Aldosterone; Body Weight; Corticosterone; Cushing Syndrome; Furosemide; Humans; Hydrochlorothiazide; | 1974 |